Abstract C200: Second-generation PIM inhibitors exhibit improved activity in solid tumor models in vitro.Jason M. Foulks, Steven B. Kanner, Yong Xu et al.|Molecular Cancer Therapeutics|2011Cited by 1
Abstract 3762: Second generation PIM inhibitors exhibit improved activity in solid tumor modelsJason M. Foulks, Steven B. Kanner, Benjamin Brenning et al.|Cancer Research|2012Cited by 1